Hyperbranched PEI with various oligosaccharide architectures: Synthesis, characterization, ATP complexation, and cellular uptake properties

Biomacromolecules

Volumn 10, Issue 5, 2009, Pages 1114-1124

  Appelhans, Dietmar ^a   Komber, Hartmut ^a   Quadir, Mohiuddin Abdul ^b   Richter, Sven ^a   Schwarz, Simona ^a   Van Der Vlist, Jereon ^c   Aigner, Achim ^d   Müller, Martin ^a   Loos, Katja ^c   Seidel, Jürgen ^e   Arndt, Karl Friedrich ^f   Haag, Rainer ^b   Voit, Brigitte ^a  

^a LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e TU BERGAKADEMIE FREIBERG   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE MOLECULES; CARRIER SYSTEMS; CELLULAR UPTAKE; CORE-SHELL; ELEMENTAL ANALYSIS; FUNCTIONALIZED; HYPERBRANCHED; IN-VITRO; ISOTHERMAL TITRATION CALORIMETRY; NMR SPECTROSCOPY; NONCOVALENT COMPLEXATION; PHYSIOLOGICAL CONDITION; POLYCATIONS; POLYELECTROLYTE TITRATION; POLYMERIC DELIVERY; REDUCTIVE AMINATION; SYNTHETIC METHODS;

AMINES; BINDING ENERGY; DENDRIMERS; EXPERIMENTS; FUNCTIONAL POLYMERS; MOLECULES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOSACCHARIDES; POLYMER BLENDS; SUGAR (SUCROSE); TITRATION;

COMPLEXATION;

ADENOSINE TRIPHOSPHATE; OLIGOSACCHARIDE; POLYETHYLENEIMINE; SUGAR;

AMINATION; ARTICLE; COMPLEX FORMATION; DYNAMIC LIGHT SCATTERING; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STATIC LIGHT SCATTERING; SYNTHESIS; TITRIMETRY;

ADENOSINE TRIPHOSPHATE; CALORIMETRY; DRUG CARRIERS; HEPATOCYTES; HUMANS; HYDROGEN-ION CONCENTRATION; IMINES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; OLIGOSACCHARIDES; POLYETHYLENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 66149138398     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm801310d     Document Type: Article

References (58)

1. Koo, O. M.; Rubinstein, I. Onyuksel, H. Nanomedicine 2005, 1, 193-212.
2. Duncan, R. Nat. Rev. Cancer 2006, 6, 688-701.
3. Haag, R.; Kratz, F. Angew. Chem. 2006, 118, 1218-1237;
4. Angew. Chem., Int. Ed. 2006, 45, 1198-1215.
5. Portney, N. G.; Ozkan, M. Anal. Bioanal. Chem. 2006, 384, 620-630.
6. Kannan, R. M.; Perumal, O. P.; Kannan, S. In Biomedical Applications of Nanotechnology; Labhasetwar, V., Leslie-Pelecky, D. L., Eds.; John Wiley & Sons, Inc.: Hoboken, N.Y., 2007; p 105.
7. Gupta, U.; Agashe, H. B.; Asthana, A.; Jain, N. K. Nanomedicine 2006, 2, 66-73.
8. Dufès, C.; Uchegbu, I. F.; Schätzlein, A. G. Adv. Drug Delivery Rev. 2005, 57, 2177-2201.
9. Aigner, A. Curr. Pharm. Des. 2008, 14, 3603-3619
10. Jansen, J. F. G. A.; de Brabander-van de Berg, E. M. M.; Meijer, E. W. Science 1994, 266, 1226-1229.
11. Liu, M.; Fréchet, J. M. J. J. Controlled Release 2000, 65, 121-131.
12. Kojima, C.; Kono, K.; Maruyama, K.; Takagishi, T. Bioconjugate Chem. 2000, 11, 910-917.
13. Stiriba, S.-E.; Kautz, H.; Frey, H. J. Am. Chem. Soc. 2002, 124, 9698-9699.
14. Shen, Z.; Duan, H.; Frey, H. Adv. Mater. 2007, 19, 349-352.
15. Chen, Y.; Shen, Z.; Frey, H.; Pérez-Prieto, J.; Stiriba, S.-E. Chem. Commun. 2005, 755, 757.
16. Adeli, M.; Haag, R. J. Polym. Sci., Part A: Polym. Chem. 2006, 44, 5470-5749.
17. Xu, S.; Krämer, M.; Haag, R. J. Drug Targeting 2006, 14, 367-374.
18. Radowski, M. R.; Shukla, A.; von Berlepsch, H.; Böttcher, C.; Pickaert, G.; Rehage, H.; Haag, R. Angew. Chem., Int. Ed. 2007, 46, 1265-1269.
19. Fischer, D.; Osburg, B.; Petersen, H.; Kissel, T.; Bickel, U. Drug Metab. Dispos. 2004, 32, 983-992.
20. Boas, U.; Heegaard, P. M. H. Recent Pat. Anti-Infect. Drug Discovery 2006, 1, 333-351.
21. Gupta, U.; Agashe, H. B.; Asthana, A.; Jain, N. K. Biomacromolecules 2006, 7, 649-658.
22. Borges, A. R.; Schengrund, C.-L. Curr. Drug Targets 2005, 5, 247-254.
23. Roy, R. Trends Glycosci. Glycotechnol. 2003, 15, 291-310.
24. Bhadra, D.; Yadav, A. K.; Bhadra, S.; Jain, N. K. Int. J. Pharm. 2005, 295, 221-233.
25. Sideratou, Z.; Tsiourvas, D.; Paleos, C. M. J. Colloid Interface Sci. 2001, 242, 272-276.
26. Agashe, H. B.; Dutta, T.; Garg, M.; Jain, N. K. J. Pharm. Pharmacol. 2006, 58, 1491-1498.
27. Xu, S.; Luo, Y.; Haag, R. Macromol. Biosci. 2007, 7, 968-974.
28. Malek, A.; Czubayko, F.; Aigner, A. J. Drug Targeting 2008, 16, 124-139.
29. Ishida, T.; Wang, X.; Shimizu, T.; Nawata, K.; Kiwada, H. J. Controlled Release 2007, 122, 349-355.
30. Malek, A.; Merkel, O.; Fink, L.; Czubayko, F.; Kissel, T.; Aigner, A. Toxicol. Appl. Pharmacol. 2009, 236, 97-108.
31. Xu, S.; Luo, Y.; Gräser, R.; Warnecke, A.; Kratz, F.; Hauff, P.; Licha, K.; Haag, R. Bioorg. Med. Chem. Lett. 2009, 19, 1030-1034.
32. Dutta, T.; Jain, N. K. Biochim. Biophys. Acta 2007, 1770, 681-686.
33. Kumar, P. V.; Asthana, A.; Dutta, T.; Jain, N. K. J. Drug Targeting 2006, 14, 546-556.
34. Arima, H.; Chihara, Y.; Arizono, M.; Yamashita, S.; Wada, K.; Hirayama, F.; Uekama, K. J. Controlled Release 2006, 116, 64-74.
35. Kunath, K.; von Harpe, A.; Fischer, D.; Kissel, T. J. Controlled Release 2003, 88, 159-172.
36. Kensinger, R. D.; Yowler, B. C.; Benesi, A. J.; Schengrund, C.-L. Bioconjugate Chem. 2004, 15, 349-358.
37. Mangold, S. L.; Cloninger, M. J. Org. Biomol. Chem. 2006, 4, 2458-2465.
38. Baek, M.-K.; Roy, R. Bioorg. Med. Chem. 2002, 10, 11-17.
39. Woller, E. K.; Walter, E. D.; Morgan, J. R.; Singel, D. J.; Cloninger, M. J. J. Am. Chem. Soc. 2003, 125, 8820-8826.
40. Köhn, M.; Benito, J.; Mellet, C. O.; Lindhorst, T. K.; Garcia Fernández, J. M. ChemBioChem 2004, 5, 771-777.
41. Marotte, K.; Preville, C.; Sabin, C.; Moume-Pymbock, M.; Imberty, A.; Roy, R. Org. Biomol. Chem. 2007, 5, 2953-2961.
42. Klajnert, B.; Appelhans, D.; Komber, H.; Morgner, N.; Schwarz, S.; Richter, S.; Brutschy, B.; Ionov, M.; Tonkikh, A. K.; Bryszewska, M.; Voit, B. Chem. - Eur. J. 2008, 14, 7030-7041.
43. Quadir, M. A.; Radowski, M. R.; Kratz, F.; Licha, K.; Hauff, P.; Haag, R. J. Controlled Release 2008, 132, 289-294.
44. Krämer, M.; Pérignon, N.; Haag, R.; Marty, J.-D.; Thomann, R.; Lauthde Viguerie, N.; Mingotaud, C. Macromolecules 2005, 38, 8308-8315.
45. Diebold, S. S.; Kursa, M.; Wagner, E.; Cotten, M.; Zenke, M. J. Biol. Chem. 1999, 274, 19087-19094.
46. Grosse, S.; Aron, Y.; Honoré, I.; Thévenot, G.; Danel, C.; Roche, A.-C.; Monsigny, M.; Fajac, I. J. Gen. Med. 2004, 6, 345-356.
47. Honoré, I.; Grosse, S.; Frison, N.; Favatier, F.; Monsigny, M.; Fajac, I. J. Controlled Release 2005, 107, 537-546.
48. Zanta, M.-A.; Boussif, O.; Adib, A.; Behr, J.-P. Bioconjugate Chem. 1997, 8, 839-844.
49. Kunath, K.; von Harpe, A.; Fischer, D.; Kissel, T. J. Controlled Release 2003, 88, 159-172.
50. Brief description of reductive and encapsulation properties of oligosaccharide-shelled PEI with high degree of oligosaccharide units on PEI surface up to 75% for the formation and stabilization of Au nanoparticles, but without detailed synthetic description and characterization of these materials. Köth, A.; Koetz, J.; Appelhans, D.; Voit, B. Colloid Polym. Sci. 2008, 286, 1317-1327.
51. van der Vlist, J.; Palomo Reixach, M.; van der Maarel, M.; Dijkhuizen, L.; Schouten, A. J.; Loos, K. Macromol. Rapid Commun. 2008, 29, 1293-1297.
52. Boyko, V.; Richter, S.; Mende, M.; Schwarz, S.; Zschoche, S.; Arndt, K.-F. Macromol. Chem. Phys. 2007, 208, 710-717.
53. Baigude, H.; Katsuraya, K.; Okuyama, K.; Yachi, Y.; Sato, S.; Uryu, T. J. Polym. Sci., Part A: Polym. Chem. 2002, 40, 3622-3633.
54. Krämer, M.; Stumbe, J.-F.; Grimm, G.; Kaufmann, B.; Krüger, U.; Weber, M.; Haag, R. ChemBioChem 2004, 5, 1081-1087.
55. Hawker, C. J.; Lee, R.; Fréchet, J. M. J. J. Am. Chem. Soc. 1991, 113, 4583-4588.
56. Toshima, N.; Kanemaru, M.; Shiraishi, Y.; Koga, Y. J. Phys. Chem. B 2005, 109, 16326-16331.
57. Rajalingam, D.; Krishnaswamy, S. K.; Chin, Y. Biochemistry 2005, 44, 14431-14442.
58. Rose, J. B.; Coe, I. R. Physiology 2008, 23, 41-48.